Actual Medicinal Product (AMP) Vipidia 6.25mg tablets (DE Pharmaceuticals)

This product can't be added to an MCA list.

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Alogliptin 6.25mg film coated tablets (Takeda UK Ltd).

Generic
Alogliptin
Formulation
Alogliptin 6.25mg tablets
  • Alogliptin
    • Alogliptin 6.25mg tablets

      • Vipidia 6.25mg tablets (DE Pharmaceuticals)